|
| 37951777 | Not without Context-A Multiple Methods Study on Evaluation and Correction of Automated Brain Tumor Segmentations by Experts. | Acad Radiol | 2024 |
| 35917833 | Artificial intelligence (AI)-based decision support improves reproducibility of tumor response assessment in neuro-oncology: An international multi-reader study. | Neuro Oncol | 2023 |
| 37774317 | RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. | J Clin Oncol | 2023 |
| 37027809 | Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma. | J Clin Oncol | 2023 |
| 36702828 | Author Correction: Federated learning enables big data for rare cancer boundary detection. | Nat Commun | 2023 |
| 36239925 | Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions. | Neuro Oncol | 2023 |
| 34015129 | Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results. | Neuro Oncol | 2022 |
| 35436952 | Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics. | Cancer Imaging | 2022 |
| 35395080 | Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma. | Clin Cancer Res | 2022 |
| 35483906 | Radiomics-Based Machine Learning for Outcome Prediction in a Multicenter Phase II Study of Programmed Death-Ligand 1 Inhibition Immunotherapy for Glioblastoma. | AJNR Am J Neuroradiol | 2022 |
| 36470898 | Federated learning enables big data for rare cancer boundary detection. | Nat Commun | 2022 |
| 36136975 | Diagnostic yield of diffusion-weighted brain MR imaging in patients with cognitive impairment: Large cohort study with 3,298 patients. | PLoS One | 2022 |
| 34611696 | Body CT and PET/CT detection of extracranial lymphoma in patients with newly diagnosed central nervous system lymphoma. | Neuro Oncol | 2022 |
| 34695182 | BOLD asynchrony: An imaging biomarker of tumor burden in IDH-mutated gliomas. | Neuro Oncol | 2022 |
| 34563433 | Imaging Advances for Central Nervous System Tumors. | Hematol Oncol Clin North Am | 2022 |
| 32812800 | Diagnostic Yield of Body CT and Whole-Body FDG PET/CT for Initial Systemic Staging in Patients With Suspected Primary CNS Lymphoma: A Systematic Review and Meta-Analysis. | AJR Am J Roentgenol | 2021 |
| 33521640 | Standardization of imaging methods for machine learning in neuro-oncology. | Neurooncol Adv | 2021 |
| 33917961 | The Incidence of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2021 |
| 33750227 | Artificial Intelligence Augmentation of Radiologist Performance in Distinguishing COVID-19 from Pneumonia of Other Origin at Chest CT. | Radiology | 2021 |
| 34409295 | Analysis of morphological characteristics of IDH-mutant/wildtype brain tumors using whole-lesion phenotype analysis. | Neurooncol Adv | 2021 |
| 34551090 | Corrigendum to: Deep learning-based automatic tumor burden assessment of pediatric high-grade gliomas, medulloblastomas, and other leptomeningeal seeding tumors. | Neuro Oncol | 2021 |
| 34037408 | Development of Brain Metastases in Patients With Non-Small Cell Lung Cancer and No Brain Metastases at Initial Staging Evaluation: Cumulative Incidence and Risk Factor Analysis. | AJR Am J Roentgenol | 2021 |
| 34282799 | The Incidence and Treatment Response of Double Expression of MYC and BCL2 in Patients with Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2021 |
| 33241519 | Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis. | Eur Radiol | 2021 |
| 33409784 | The T2-FLAIR mismatch sign as a predictor of IDH-mutant, 1p/19q-noncodeleted lower-grade gliomas: a systematic review and diagnostic meta-analysis. | Eur Radiol | 2021 |
| 33289357 | Immune Checkpoint Inhibitor with or without Radiotherapy in Melanoma Patients with Brain Metastases: A Systematic Review and Meta-Analysis. | Korean J Radiol | 2021 |
| 32322066 | Mechanisms and therapeutic implications of hypermutation in gliomas. | Nature | 2020 |
| 32048719 | Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases. | Neuro Oncol | 2020 |
| 31761063 | Imaging of Central Nervous System Tumors Based on the 2016 World Health Organization Classification. | Neurol Clin | 2020 |
| 33177576 | Differentiation of low and high grade renal cell carcinoma on routine MRI with an externally validated automatic machine learning algorithm. | Sci Rep | 2020 |
| 32661052 | Automatic Machine Learning to Differentiate Pediatric Posterior Fossa Tumors on Routine MR Imaging. | AJNR Am J Neuroradiol | 2020 |
| 32840470 | Diagnostic Yield of Staging Brain MRI in Patients with Newly Diagnosed Non-Small Cell Lung Cancer. | Radiology | 2020 |
| 32530764 | Ivosidenib in Isocitrate Dehydrogenase 1<i>-</i>Mutated Advanced Glioma. | J Clin Oncol | 2020 |
| 32339081 | Artificial Intelligence Augmentation of Radiologist Performance in Distinguishing COVID-19 from Pneumonia of Other Origin at Chest CT. | Radiology | 2020 |
| 32215549 | Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical data. | Neuro Oncol | 2020 |
| 32328653 | Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. | Neuro Oncol | 2020 |
| 30661193 | Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas. | J Neurooncol | 2019 |
| 32642653 | The effect of brain metastasis location on clinical outcomes: A review of the literature. | Neurooncol Adv | 2019 |
| 30085283 | Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression. | Neuro Oncol | 2019 |
| 30137421 | Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group. | Neuro Oncol | 2019 |
| 31596185 | Using 3D MRI Anatomic Maps to Determine Prognosis for Glioblastomas. | Radiology | 2019 |
| 31190077 | Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurement. | Neuro Oncol | 2019 |
| 30720861 | Artificial intelligence in cancer imaging: Clinical challenges and applications. | CA Cancer J Clin | 2019 |
| 30715520 | A low percentage of metastases in deep brain and temporal lobe structures. | Neuro Oncol | 2019 |
| 30268583 | CT-Guided Percutaneous Spine Biopsy Specimen Adequacy, Pathology Concordance, and Negative Predictive Value with Battery-Powered Drill and Manual Approaches. | Curr Probl Diagn Radiol | 2019 |
| 30649491 | Imaging and diagnostic advances for intracranial meningiomas. | Neuro Oncol | 2019 |
| 30648771 | Functional MRI Task Comparison for Language Mapping in Neurosurgical Patients. | J Neuroimaging | 2019 |
| 29294069 | The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology. | Neuro Oncol | 2018 |
| 30220316 | Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma. | Oral Oncol | 2018 |
| 30082232 | CT and MRI Protocol Variation and Optimization at an Academic Medical Center. | J Am Coll Radiol | 2018 |